Alkermes plc. Share-based Payment Arrangement, Expense
Alkermes plc. (ALKS) reported Share-based Payment Arrangement, Expense of $31.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-07-28
- Alkermes plc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $31.14M, a 24.73% increase year-over-year.
- Alkermes plc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $36.33M, a 59.27% increase year-over-year.
- Alkermes plc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $24.97M, a 21.19% increase year-over-year.
- Alkermes plc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $22.81M, a 30.36% decline year-over-year.
- Alkermes plc. share-based payment arrangement, expense for fiscal 2025 was $98.72M, a 2.15% increase from fiscal 2024.
- Alkermes plc. share-based payment arrangement, expense for fiscal 2024 was $96.64M, a 4.23% decline from fiscal 2023.
- Alkermes plc. share-based payment arrangement, expense for fiscal 2023 was $100.91M, a 7.06% increase from fiscal 2022.
- Alkermes plc. share-based payment arrangement, expense for fiscal 2022 was $94.25M, a 7.57% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $31.14M 10-Q · filed 2026-07-28 | $67.47M 10-Q · filed 2026-07-28 | ||
| 2026-03-31 | $36.33M 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | $98.72M 10-K · filed 2026-02-25 | |||
| 2025-06-30 | $24.97M 10-Q · filed 2026-07-28 | $47.78M 10-Q · filed 2026-07-28 | $68.52M derived: sum of 3 quarters · filed 2026-07-28 | $91.06M derived: sum of 4 quarters · filed 2026-07-28 |
| 2025-03-31 | $22.81M 10-Q · filed 2026-05-05 | $43.56M derived: sum of 2 quarters · filed 2026-05-05 | $66.09M derived: sum of 3 quarters · filed 2026-05-05 | $86.69M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $20.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $43.28M derived: sum of 2 quarters · filed 2026-02-25 | $63.88M derived: sum of 3 quarters · filed 2026-02-25 | $96.64M 10-K · filed 2026-02-25 |
| 2024-09-30 | $22.53M 10-Q · filed 2024-10-24 | $43.13M derived: sum of 2 quarters · filed 2024-10-24 | $75.89M 10-Q · filed 2024-10-24 | $101.73M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $20.60M 10-Q · filed 2024-07-24 | $53.36M 10-Q · filed 2024-07-24 | $79.20M derived: sum of 3 quarters · filed 2026-02-25 | $103.11M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $32.76M 10-Q · filed 2024-05-01 | $58.60M derived: sum of 2 quarters · filed 2026-02-25 | $82.51M derived: sum of 3 quarters · filed 2026-02-25 | $111.02M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $25.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $49.76M derived: sum of 2 quarters · filed 2026-02-25 | $78.26M derived: sum of 3 quarters · filed 2026-02-25 | $100.91M 10-K · filed 2026-02-25 |
| 2023-09-30 | $23.91M 10-Q · filed 2024-10-24 | $52.42M derived: sum of 2 quarters · filed 2024-10-24 | $75.06M 10-Q · filed 2024-10-24 | $101.55M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | $28.50M 10-Q · filed 2024-07-24 | $51.15M 10-Q · filed 2024-07-24 | $77.63M derived: sum of 3 quarters · filed 2025-02-12 | $103.68M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | $22.64M 10-Q · filed 2024-05-01 | $49.13M derived: sum of 2 quarters · filed 2025-02-12 | $75.18M derived: sum of 3 quarters · filed 2025-02-12 | $98.55M derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | $26.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $52.53M derived: sum of 2 quarters · filed 2025-02-12 | $75.91M derived: sum of 3 quarters · filed 2025-02-12 | $94.25M 10-K · filed 2025-02-12 |
| 2022-09-30 | $26.05M 10-Q · filed 2023-10-25 | $49.43M derived: sum of 2 quarters · filed 2023-10-25 | $67.77M 10-Q · filed 2023-10-25 | $86.79M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $23.38M 10-Q · filed 2023-07-26 | $41.72M 10-Q · filed 2023-07-26 | $60.74M derived: sum of 3 quarters · filed 2024-02-21 | $86.34M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $18.34M 10-Q · filed 2023-04-26 | $37.36M derived: sum of 2 quarters · filed 2024-02-21 | $62.96M derived: sum of 3 quarters · filed 2024-02-21 | $90.51M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $19.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $44.62M derived: sum of 2 quarters · filed 2024-02-21 | $72.17M derived: sum of 3 quarters · filed 2024-02-21 | $87.62M 10-K · filed 2024-02-21 |
| 2021-09-30 | $25.60M 10-Q · filed 2022-11-02 | $53.15M derived: sum of 2 quarters · filed 2022-11-02 | $68.60M 10-Q · filed 2022-11-02 | $93.49M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $27.55M 10-Q · filed 2022-07-27 | $43.00M 10-Q · filed 2022-07-27 | $67.89M derived: sum of 3 quarters · filed 2023-02-16 | $90.51M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $15.45M 10-Q · filed 2022-04-27 | $40.34M derived: sum of 2 quarters · filed 2023-02-16 | $62.96M derived: sum of 3 quarters · filed 2023-02-16 | $85.80M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $24.89M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $47.51M derived: sum of 2 quarters · filed 2023-02-16 | $70.35M derived: sum of 3 quarters · filed 2023-02-16 | $90.16M 10-K · filed 2023-02-16 |
| 2020-09-30 | $22.62M 10-Q · filed 2021-10-27 | $45.47M derived: sum of 2 quarters · filed 2021-10-27 | $65.28M 10-Q · filed 2021-10-27 | $86.67M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $22.85M 10-Q · filed 2021-07-28 | $42.66M 10-Q · filed 2021-07-28 | $64.05M derived: sum of 3 quarters · filed 2022-02-16 | $90.78M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $19.81M 10-Q · filed 2021-04-28 | $41.20M derived: sum of 2 quarters · filed 2022-02-16 | $67.93M derived: sum of 3 quarters · filed 2022-02-16 | $96.17M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $21.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $48.12M derived: sum of 2 quarters · filed 2022-02-16 | $76.36M derived: sum of 3 quarters · filed 2022-02-16 | $100.98M 10-K · filed 2022-02-16 |
| 2019-09-30 | $26.73M 10-Q · filed 2020-10-29 | $54.97M derived: sum of 2 quarters · filed 2020-10-29 | $79.59M 10-Q · filed 2020-10-29 | $108.90M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | $28.25M 10-Q · filed 2020-07-29 | $52.86M 10-Q · filed 2020-07-29 | $82.17M derived: sum of 3 quarters · filed 2021-02-11 | $107.24M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | $24.62M 10-Q · filed 2020-04-29 | $53.93M derived: sum of 2 quarters · filed 2021-02-11 | $79.00M derived: sum of 3 quarters · filed 2021-02-11 | $109.93M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | $29.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $54.38M derived: sum of 2 quarters · filed 2021-02-11 | $85.31M derived: sum of 3 quarters · filed 2021-02-11 | $105.36M 10-K · filed 2021-02-11 |
| 2018-09-30 | $25.07M 10-Q · filed 2019-10-23 | $56.00M derived: sum of 2 quarters · filed 2019-10-23 | $76.04M 10-Q · filed 2019-10-23 | $96.62M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $30.93M 10-Q · filed 2019-07-25 | $50.98M 10-Q · filed 2019-07-25 | $71.56M derived: sum of 3 quarters · filed 2020-02-13 | $91.04M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | $20.04M 10-Q · filed 2019-04-25 | $40.62M derived: sum of 2 quarters · filed 2020-02-13 | $60.11M derived: sum of 3 quarters · filed 2020-02-13 | $82.79M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | $20.58M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $40.07M derived: sum of 2 quarters · filed 2020-02-13 | $62.75M derived: sum of 3 quarters · filed 2020-02-13 | $83.92M 10-K · filed 2020-02-13 |
| 2017-09-30 | $19.49M 10-Q · filed 2018-10-23 | $42.17M derived: sum of 2 quarters · filed 2018-10-23 | $63.34M 10-Q · filed 2018-10-23 | $83.12M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $22.68M 10-Q · filed 2018-07-26 | $43.85M 10-Q · filed 2018-07-26 | $63.63M derived: sum of 3 quarters · filed 2019-02-15 | $87.36M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $21.17M 10-Q · filed 2018-04-26 | $40.95M derived: sum of 2 quarters · filed 2019-02-15 | $64.68M derived: sum of 3 quarters · filed 2019-02-15 | $91.31M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $19.78M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $43.51M derived: sum of 2 quarters · filed 2019-02-15 | $70.14M derived: sum of 3 quarters · filed 2019-02-15 | $94.40M 10-K · filed 2019-02-15 |
| 2016-09-30 | $23.73M 10-Q · filed 2017-10-26 | $50.36M derived: sum of 2 quarters · filed 2017-10-26 | $74.61M 10-Q · filed 2017-10-26 | $97.48M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $26.63M 10-Q · filed 2017-07-27 | $50.89M 10-Q · filed 2017-07-27 | $73.75M derived: sum of 3 quarters · filed 2018-02-16 | $109.02M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $24.26M 10-Q · filed 2017-04-27 | $47.12M derived: sum of 2 quarters · filed 2018-02-16 | $82.39M derived: sum of 3 quarters · filed 2018-02-16 | $104.27M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $22.87M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $58.13M derived: sum of 2 quarters · filed 2018-02-16 | $80.01M derived: sum of 3 quarters · filed 2018-02-16 | $97.34M 10-K · filed 2018-02-16 |
| 2015-09-30 | $35.27M 10-Q · filed 2016-11-02 | $57.14M derived: sum of 2 quarters · filed 2016-11-02 | $74.47M 10-Q · filed 2016-11-02 | $87.81M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $21.88M 10-Q · filed 2016-07-28 | $39.21M 10-Q · filed 2016-07-28 | $52.55M derived: sum of 3 quarters · filed 2017-02-17 | $66.03M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $17.33M 10-Q · filed 2016-04-28 | $30.67M derived: sum of 2 quarters · filed 2017-02-17 | $44.15M derived: sum of 3 quarters · filed 2017-02-17 | $63.49M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $13.34M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $26.82M derived: sum of 2 quarters · filed 2017-02-17 | $46.16M derived: sum of 3 quarters · filed 2017-02-17 | $59.58M 10-K · filed 2017-02-17 |
| 2014-09-30 | $13.48M 10-Q · filed 2015-10-29 | $32.82M derived: sum of 2 quarters · filed 2015-10-29 | $46.24M 10-Q · filed 2015-10-29 | $56.63M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | $19.34M 10-Q · filed 2015-07-30 | $32.76M 10-Q · filed 2015-07-30 | $43.15M derived: sum of 3 quarters · filed 2016-02-25 | $57.36M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | $13.42M 10-Q · filed 2015-04-30 | $23.81M derived: sum of 2 quarters · filed 2016-02-25 | $38.02M derived: sum of 3 quarters · filed 2016-02-25 | $46.83M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | $10.39M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $24.60M derived: sum of 2 quarters · filed 2016-02-25 | $33.41M 10-K · filed 2016-02-25 | $41.29M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-09-30 | $14.21M 10-Q · filed 2014-10-29 | $23.02M 10-Q · filed 2013-10-31 | $30.90M 10-Q · filed 2014-10-29 | $39.13M derived: sum of 4 quarters · filed 2014-10-29 |
| 2013-06-30 | $8.81M 10-Q · filed 2014-07-31 | $16.69M 10-Q · filed 2014-07-31 | $24.92M derived: sum of 3 quarters · filed 2014-07-31 | $35.36M derived: sum of 4 quarters · filed 2014-07-31 |
| 2013-03-31 | $7.88M 10-Q · filed 2014-04-30 | $16.11M derived: sum of 2 quarters · filed 2014-04-30 | $26.55M derived: sum of 3 quarters · filed 2014-04-30 | $34.72M 10-K · filed 2015-02-24 |
| 2012-12-31 | $8.23M 10-Q · filed 2013-01-31 | $18.67M derived: sum of 2 quarters · filed 2013-10-31 | $26.84M 10-Q · filed 2013-01-31 | $33.92M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-09-30 | $10.45M 10-Q · filed 2013-10-31 | $18.61M 10-Q · filed 2013-10-31 | $25.69M derived: sum of 3 quarters · filed 2014-02-27 | $34.72M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-06-30 | $8.16M 10-Q · filed 2013-07-25 | $15.24M derived: sum of 2 quarters · filed 2014-02-27 | $24.28M derived: sum of 3 quarters · filed 2014-02-27 | $31.33M derived: sum of 4 quarters · filed 2014-02-27 |
| 2012-03-31 | $7.08M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $16.11M derived: sum of 2 quarters · filed 2014-02-27 | $23.17M derived: sum of 3 quarters · filed 2014-02-27 | $28.83M 10-KT · filed 2014-02-27 |
| 2011-12-31 | $9.03M 10-Q · filed 2013-01-31 | $16.08M derived: sum of 2 quarters · filed 2013-01-31 | $21.74M 10-Q · filed 2013-01-31 | |
| 2011-09-30 | $7.05M 10-Q · filed 2012-11-01 | $12.71M 10-Q · filed 2012-11-01 | ||
| 2011-06-30 | $5.66M 10-Q · filed 2012-07-26 | |||
| 2011-03-31 | $19.83M 10-K · filed 2013-05-23 | |||
| 2010-03-31 | $13.92M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |